BPG is committed to discovery and dissemination of knowledge
Articles Published Processes
10/31/2024 7:40:50 AM | Browse: 332 | Download: 711
Publication Name World Journal of Experimental Medicine
Manuscript ID 99239
Country India
ISSN 2220-315x (online)
Open Access This article is an open-access article that was selected by an in-house editor and fully peer-reviewed by external reviewers. It is distributed in accordance with the Creative Commons Attribution NonCommercial (CC BY-NC 4.0) license, which permits others to distribute, remix, adapt, build upon this work non-commercially, and license their derivative works on different terms, provided the original work is properly cited and the use is non-commercial. See: https://creativecommons.org/Licenses/by-nc/4.0/
Copyright The Author(s) 2024. Published by Baishideng Publishing Group Inc. All rights reserved.
Article Reprints For details, please visit: http://www.wjgnet.com/bpg/gerinfo/247
Permissions For details, please visit: http://www.wjgnet.com/bpg/gerinfo/207
Publisher Baishideng Publishing Group Inc, 7041 Koll Center Parkway, Suite 160, Pleasanton, CA 94566, USA
Website http://www.wjgnet.com
Category Endocrinology & Metabolism
Manuscript Type Minireviews
Article Title Melanocortin 4 receptor mutation in obesity
Manuscript Source Invited Manuscript
All Author List Gumpeny R Sridhar and Lakshmi Gumpeny
ORCID
Author(s) ORCID Number
Gumpeny R Sridhar http://orcid.org/0000-0002-7446-1251
Lakshmi Gumpeny http://orcid.org/0000-0002-1368-745X
Funding Agency and Grant Number
Corresponding Author Gumpeny R Sridhar, FRCP (Hon), Adjunct Professor, Department of Endocrinology and Diabetes, Endocrine and Diabetes Centre, 15-12-15 Krishnanagar, Visakhapatnam 530002, Andhra Pradesh, India. sridharvizag@gmail.com
Key Words Leptin-melanocortin pathway; Downstream; G protein; Cyclic AMP; Mutation; Obesity syndromes; Screening; Setmelanotide
Core Tip The leptin-melanocortin pathway regulates energy balance and body weight. Melanocortin-4 receptor (MC4R) plays a key role in this pathway by reducing hunger, inducing satiety and increasing energy expenditure. Mutations of MC4R result in obesity and hyperphagia in childhood. Setmelanotide is an MC4R agonist approved for use in obesity caused by leptin-melanocortin pathway dysfunction.
Publish Date 2024-10-31 07:40
Citation

Sridhar GR, Gumpeny L. Melanocortin 4 receptor mutation in obesity. World J Exp Med 2024; 14(4): 99239

URL https://www.wjgnet.com/2220-315x/full/v14/i4/99239.htm
DOI https://dx.doi.org/10.5493/wjem.v14.i4.99239
Full Article (PDF) WJEM-14-99239-with-cover.pdf